PAVM Price / FCF | PAVmed Inc.

PAVmed Inc. Price-FCF Ratio

The price-to-free-cash-flow (P/FCF) ratio tells you how many dollars investors pay for each dollar of cash a company generates after paying for its capital spending. It is market capitalization divided by free cash flow over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher ratio means investors are paying more for each dollar of free cash flow; a negative ratio means the company spent more cash than it generated over those quarters. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.

PAVmed Inc. price-fcf ratio for the quarter ending 2026-06-30 was -4.66, a change of -3.62 year-over-year.
PAVmed Inc. price-fcf ratio for the quarter ending 2026-03-31 was -9.53, a change of 6.92 year-over-year.
PAVmed Inc. price-fcf ratio for the quarter ending 2025-12-31 was -0.04, a change of 0.17 year-over-year.
PAVmed Inc. price-fcf ratio for the quarter ending 2025-09-30 was -2.81, a change of 5.79 year-over-year.
PAVmed Inc. price-fcf ratio for fiscal 2026 was -4.66.
PAVmed Inc. price-fcf ratio for fiscal 2025 was -0.04, a change of 0.17 from fiscal 2024.
PAVmed Inc. price-fcf ratio for fiscal 2024 was -0.21, a change of 20.07 from fiscal 2023.
PAVmed Inc. price-fcf ratio for fiscal 2023 was -20.28, a change of -1.52 from fiscal 2022.

Available history: 2016-12-31 to 2026-06-30
Data captured: 2026-06-30

Historical Price-FCF Ratio

Date	Price-FCF Ratio	Market capitalization	Free cash flow 12 month
2026-06-30	-4.66	$36.3M	-$7.78M
2026-03-31	-9.53	$59.97M	-$6.29M
2025-12-31	-0.04	$200,062.57	-$5.24M
2025-09-30	-2.81	$10.06M	-$3.58M
2025-06-30	-1.04	$12.09M	-$11.57M
2025-03-31	-16.45	$362.73M	-$22.05M
2024-12-31	-0.21	$7.03M	-$33.61M
2024-09-30	-8.6	$393.37M	-$45.76M
2024-06-30	-4.87	$233.6M	-$47.97M
2024-03-31	-11.6	$568.72M	-$49.04M
2023-12-31	-20.28	$1.06B	-$52.28M
2023-09-30	-277.12	$15.89B	-$57.34M
2023-06-30	-302.43	$19.93B	-$65.89M
2023-03-31	-222.55	$16.93B	-$76.08M
2022-12-31	-18.77	$1.36B	-$72.53M
2022-09-30	-485.89	$35.69B	-$73.46M
2022-06-30	-591.96	$36.62B	-$61.85M
2022-03-31	-1,129.83	$51.63B	-$45.69M
2021-12-31	-2,273.16	$95.61B	-$42.06M
2021-09-30	-10,550.79	$324.35B	-$30.74M
2021-06-30	-8,335.25	$237.82B	-$28.53M
2021-03-31	-5,941.81	$162.69B	-$27.38M
2020-12-31	-2,771.37	$60.88B	-$21.97M
2020-09-30	-2,058.18	$39.77B	-$19.33M
2020-06-30	-2,781.12	$45.5B	-$16.36M
2020-03-31	-2,955.74	$39.32B	-$13.3M
2019-12-31	-1,633.19	$21.86B	-$13.38M
2019-09-30	-1,281.09	$15.78B	-$12.31M
2017-12-31	-2,262.39	$14.96B	-$6.61M
2017-09-30	-5,233.85	$32.6B	-$6.23M
2017-06-30	-5,307.16	$27.02B	-$5.09M
2017-03-31	-5,193.22	$30B	-$5.78M
2016-12-31	-9,246.24	$41.39B	-$4.48M

Annual Price-FCF Ratio

Date	Price-FCF Ratio	Market capitalization	Free cash flow 12 month
2026-06-30	-4.66	$36.3M	-$7.78M
2025-12-31	-0.04	$200,062.57	-$5.24M
2024-12-31	-0.21	$7.03M	-$33.61M
2023-12-31	-20.28	$1.06B	-$52.28M
2022-12-31	-18.77	$1.36B	-$72.53M
2021-12-31	-2,273.16	$95.61B	-$42.06M
2020-12-31	-2,771.37	$60.88B	-$21.97M
2019-12-31	-1,633.19	$21.86B	-$13.38M
2017-12-31	-2,262.39	$14.96B	-$6.61M
2016-12-31	-9,246.24	$41.39B	-$4.48M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
InspireMD, Inc. (NSPR)		$0.033B
Glucotrack, Inc. (GCTK)	United States	$0.027B
ACCURAY INC (ARAY)	United States	$0.027B	-0.63
HeartBeam, Inc. (BEAT)	United States	$0.022B	-2.08
SANUWAVE Health, Inc. (SNWV)	United States	$0.041B	5.47
RETRACTABLE TECHNOLOGIES INC (RVP)	United States	$0.021B	-6.44
FEMASYS INC (FEMY)	United States	$0.020B	-1.07
Modular Medical, Inc. (MODD)	United States	$0.018B	-0.88
NEPHROS INC (NEPH)	United States	$0.046B	23.02
SeaStar Medical Holding Corp (ICU)	United States	$0.015B	-1.14